Another CDK inhibitor, dinaciclib, synergized with the novel HSP90 inhibitor HAA2020 and displayed stronger apoptotic and cell cycle control properties in acute myeloid leukemia (AML) [100]. This evidence concerns the gene HSP90AB1 and acute myeloid leukemia.